Autumn finds hope at NIH and The Children's Inn for Neurofibromatosis Type 1

Donate to support children like Autumn: https://bit.ly/2ShF6yf Read more about Autumn and how your support of The Children’s Inn is making a big difference for her and NIH clinical research: https://childrensinn.org/a-proud-nih-... Autumn is a vivacious 9-year-old with boundless energy and a big heart for people and animals. For the past seven years, the frequent Inn resident has also been an important partner in research for the National Cancer Institute.This April, Autumn’s clinical trial participation culminated in a major medical breakthrough: U.S. Food and Drug Administration approval of the first treatment for inoperable tumors caused by neurofibromatosis type 1 (NF1), an often devastating tumor predisposition disorder.